Hiding in Plain Sight: A Multidisciplinary Effort to Improve -

Thank you for attending.

Attendees who meet the required instructional time established will receive an email with a link to obtain credit within 48 hours of the program's completion.

Note for ODs: COPE guidelines dictate that in order to receive credit, learners must remain present at the synchronous virtual activity until the end of the program. Attendees who meet the required instructional time established by COPE will receive an email with a link to obtain credit within 48 hours of the program's completion.

Scroll back to top

Details

Overview
Thyroid eye disease (TED) is the most common noninfectious, autoimmune disease that leads to inflammation and enlargement of the orbital and retro-orbital muscles and connective and fat tissues.
Join Drs. Kossler, Murdock, and Bloomgarden for a discussion on how to recognize the signs and symptoms of this complex disease and effective comanagement strategies to improve outcomes for patients with TED.

Note About Obtaining COPE Credit: You must remain logged in to the synchronous virtual activity until the end of the program. Attendees who meet the required instructional time established by COPE will receive an email with a link to obtain credit within 48 hours of the program's completion.
The posttest will not be available immediately. It will be accessible once the link has been emailed to you, which will be within 48 hours of the conclusion of the symposium.
To receive credit, you must complete the posttest and evaluation and proceed to the claim credit page. Only attendees are eligible for credit.

This activity is supported by an unrestricted educational grant from Horizon Therapeutics.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Recognize the prevalence and risk factors for TED
- Describe the clinical signs and symptoms, grading system, and tests/imaging used to diagnose TED
- Review the differential diagnosis for TED
- Evaluate clinical and real-world data investigating the use of biologics in patients with TED
- Implement educational practices that improve patient knowledge of TED diagnosis, management, and treatment
- Develop effective comanagement strategies to improve outcomes for patients with TED
Accreditation
Provided by Evolve Medical Education

Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Evolve Medical Education LLC (Evolve) is a COPE-accredited administrator.
This activity, COPE Activity Number 126570, is accredited by COPE for continuing education for optometrists. This course is approved for 1.5 hours of CE.
Course #: 85898-SD
Activity #: 126570
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
Participation Method
In order to obtain credit, proceed through the program, complete the posttest, evaluation and submit for credit.
Faculty and Disclosures
Andrea Kossler, MD, FACS
Associate Professor of Ophthalmology
Stanford School of Medicine
Palo Alto, CA

Jennifer Murdock, MD
Oculofacial Plastic and Reconstructive Surgeon
Miami, FL

Eve Bloomgarden, MD
Director of Thyroid Care
Director of Endocrine Innovation and Education
Division of Endocrinology NorthShore University Health Systems
Evanston, IL

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Andrea Kossler, MD, FACS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Acelyrin, Argenx, Genentech, Horizon Therapeutics, Immunovant, and Kriya Therapeutics. Grant/Research Support: Horizon Therapeutics, Kriya Therapeutics, Sling, and Viridian.
Jennifer Murdock, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alastin Skincare, Galderma Laboratories, and Horizon Therapeutics. Speaker's Bureau: Horizon Therapeutics.
Eve Bloomgarden, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Horizon Therapeutics.
The Evolve staff, planners, and reviewer have no financial relationships with ineligible companies.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Horizon Therapeutics.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Note About Obtaining COPE Credit: You must remain logged in to the synchronous virtual activity until the end of the program. Attendees who meet the required instructional time established by COPE will receive an email with a link to obtain credit within 48 hours of the program's completion.
The posttest will not be available immediately. It will be accessible once the link has been emailed to you, which will be within 48 hours of the conclusion of the symposium.
To receive credit, you must complete the posttest and evaluation and proceed to the claim credit page. Only attendees are eligible for credit.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Expiration Date: 09/08/2023

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Title

Share on ReachMD